Daniel Salazar
Directeur/Membre du Conseil chez Vero Biotech LLC
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Kenneth Joseph Keller | M | 61 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 10 ans |
Todd Brady | M | 45 |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta.
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 10 ans |
Brent Furse | M | 55 |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 8 ans |
Vinzenz Ploerer | M | - |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | - |
Richard van Dyune | M | 70 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 21 ans |
Bob Casale | M | 65 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | - |
Raymond Schinazi | M | 74 |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | - |
Luis Manuel Sánchez Carlos | - | - |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | - |
David Stocker | M | - |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 8 ans |
Ganesh Raghu | M | - |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Glenn Gormley | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | - |
Peter Blume-Jensen | M | 62 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | - |
John Gargiulo | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 2 ans |
Louka T. Katseli | M | 72 |
Princeton University
| 4 ans |
Craig B. Bleifer | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 18 ans |
William Frist | M | 72 |
Princeton University
| 4 ans |
Mark Linton | M | - |
Princeton University
| 4 ans |
Peter D. Cleary | M | - |
Princeton University
| 4 ans |
Lorne Hill | M | - |
Princeton University
| 4 ans |
David M. Abromowitz | M | - |
Princeton University
| 4 ans |
Michael A. Tanenbaum | M | - |
Princeton University
| 4 ans |
David Salomon | M | - |
Princeton University
| 4 ans |
Scott Hayworth | M | - |
Princeton University
| 4 ans |
Abigail E. Laufer | F | - |
Princeton University
| 4 ans |
Lorenz Muller | M | 60 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 7 ans |
Scott Gottlieb | M | 51 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 2 ans |
William P. Urschel | M | - |
Princeton University
| 4 ans |
Mary Cardosa | M | - |
Princeton University
| 4 ans |
Elizabeth Najeeb Halaby | F | - |
Princeton University
| 4 ans |
William Walton | M | 72 |
Princeton University
| 4 ans |
Alan D. Smith | M | - |
Princeton University
| 4 ans |
Rebecca M. Bergman | F | 66 |
Princeton University
| 4 ans |
Jeffrey Gaither Sullivan | M | - |
Princeton University
| 4 ans |
Joseph P. Pieroni | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | - |
Christine K. Chiou | F | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | - |
Mahmoud Ghazzi | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 5 ans |
Nicholas Allard | M | - |
Princeton University
| 4 ans |
Barry Wihak | M | - |
Princeton University
| 4 ans |
Dori Walton | F | - |
Princeton University
| 4 ans |
Kevin Toner | M | - |
Princeton University
| 4 ans |
Kim Wix | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 11 ans |
Nenad Sarapa | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 2 ans |
Igor Matushansky | M | 51 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 2 ans |
Robert Lisicki | M | 57 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 4 ans |
Sandra Clarke | F | 55 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 1 ans |
Jim Shepard | M | - |
Princeton University
| 4 ans |
Paul D. Downs | M | - |
Princeton University
| 4 ans |
Virginia Kamsky | F | 70 |
Princeton University
| 4 ans |
Eric Richman | M | 63 |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | 2 ans |
Heidi Miller | M | 70 |
Princeton University
| 4 ans |
Jon Barfield | M | 72 |
Princeton University
| 4 ans |
Richard F. Lambert | M | 67 |
Princeton University
| 4 ans |
Danesha Dixon Smith | F | 51 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 5 ans |
Ellen DeSanctis | F | 67 |
Princeton University
| 4 ans |
Bennett Stewart | M | 71 |
Princeton University
| 4 ans |
Jonathan Javitt | M | 67 |
Princeton University
| 4 ans |
Arthur Levinson | M | 73 |
Princeton University
| 3 ans |
John Barry | M | 72 |
Princeton University
| 4 ans |
Howard Feist | M | 68 |
Princeton University
| 4 ans |
Pamela Daley | F | 71 |
Princeton University
| 4 ans |
James L. Shea | M | 70 |
Princeton University
| 4 ans |
Thomas Martin Connelly | M | 72 |
Princeton University
| 4 ans |
Tom Leighton | M | 67 |
Princeton University
| 4 ans |
Kneeland Youngblood | M | 69 |
Princeton University
| 4 ans |
Christopher Day Johnson | M | - |
Princeton University
| 4 ans |
James W. Lytle | M | - |
Princeton University
| 4 ans |
Martin Aaron Sankey | M | - |
Princeton University
| 3 ans |
John Aristotle Phillips | M | - |
Princeton University
| 4 ans |
Alan Talkington | M | - |
Princeton University
| 4 ans |
Robert A. Rosenbaum | M | - |
Princeton University
| 4 ans |
Stephen C. Ferruolo | M | - |
Princeton University
| 1 ans |
William T. Quicksilver | M | - |
Princeton University
| 4 ans |
Michael Gregory Odlum | M | - |
Princeton University
| 4 ans |
Franklin Techar | M | - |
Princeton University
| 4 ans |
Peter Kellogg | M | 67 |
Princeton University
| 4 ans |
John R. Cullinane | M | - |
Princeton University
| 4 ans |
Hiroshi Ozaki | M | 74 |
Princeton University
| 3 ans |
Kathryn Hall | F | 66 |
Princeton University
| 6 ans |
Ronald N. Kahn | M | - |
Princeton University
| 4 ans |
Eric Keith Scholl | M | 69 |
Princeton University
| 4 ans |
Jack Herbert | M | - |
Princeton University
| 4 ans |
Ellie Moffat | F | 68 |
Princeton University
| 4 ans |
Javad Shahidi | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 5 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 83 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Daniel Salazar
- Réseau Personnel